Journal of Neuro-Oncology

, Volume 75, Issue 1, pp 85–99 | Cite as

Leptomeningeal metastases from solid malignancy: a review

  • Sophie Taillibert
  • Florence Laigle-Donadey
  • Catherine Chodkiewicz
  • Marc Sanson
  • Khê Hoang-Xuan
  • Jean-Yves Delattre

Summary

Leptomeningeal metastases (LMM) consist of diffuse involvement of the leptomeninges by infiltrating cancer cells. In solid tumors, the most frequent primary sites are lung and breast cancers, two tumors where the incidence of LMM is apparently increasing. Careful neurological examination is required to demonstrate multifocal involvement of the central nervous system (CNS), cranial nerves, and spinal roots, which constitute the clinical hallmark of the disease. Cerebro-spinal fluid (CSF) analysis is almost always abnormal but only a positive cytology or demonstration of intrathecal synthesis of tumor markers is diagnostic. T1-weighted gadolinium-enhanced sequence of the entire neuraxis (brain and spine) plays an important role in supporting the diagnosis, demonstrating the involved sites and guiding treatment. Radionuclide CSF flow studies detect CSF compartmentalization and are useful for treatment planning. Standard therapy relies mainly on focal irradiation and intrathecal or systemic chemotherapy. Studies using other therapeutic approaches such as new biological or cytotoxic compounds are ongoing. The overall prognosis remains grim and quality of life should remain the priority when deciding which treatment option to apply. However, a sub-group of patients, tentatively defined here, may benefit from an aggressive treatment.

Keywords

cancer leptomeningeal carcinomatosis leptomeningeal metastases meningeal metastases neoplastic meningitis solid tumors 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Olson, ME, Chernik, NL, Posner, JB. 1974Infiltration of the leptomeninges by systemic cancerA clinical and pathologic study. Arch Neurol30122137Google Scholar
  2. 2.
    Little, JR, Dale, AJ, Okazaki, H. 1974Meningeal carcinomatosisClinical manifestations. Arch Neurol30138143Google Scholar
  3. 3.
    Shapiro, WR, Posner, JB, Ushio, Y, Chemik, NL, Young, DF. 1977Treatment of meningeal neoplasmsCancer Treat Rep61733743PubMedGoogle Scholar
  4. 4.
    Theodore, WH, Gendelman, S. 1981Meningeal carcinomatosisArch Neurol38696699PubMedGoogle Scholar
  5. 5.
    Wasserstrom, WR, Glass, JP, Posner, JB. 1982Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patientsCancer49759772PubMedGoogle Scholar
  6. 6.
    Kaplan, JG, DeSouza, TG, Farkash, A, Shafran, B, Pack, D, Rehman, F, Fuks, J, Portenoy, R. 1990Leptomeningeal metastases: comparison of clinical features and laboratory data of solid tumors, lymphomas and leukemiasJ Neurooncol9225229PubMedGoogle Scholar
  7. 7.
    Chamberlain, MC, Corey-Bloom, J. 1991Leptomeningeal metastases: 111indium-DTPA CSF flow studiesNeurology4117651769PubMedGoogle Scholar
  8. 8.
    Posner, JB, Chernik, NL 1978Intracranial metastases from systemic cancerAdv Neurol19579592PubMedGoogle Scholar
  9. 9.
    Takakura K, Sano K, Hojo S. Metastatic tumors of the central nervous system. 1982Google Scholar
  10. 10.
    Monte, SM, Moore, GW, Hutchins, GM. 1983Patterned distribution of metastases from malignant melanoma in humansCancer Res4334273433PubMedGoogle Scholar
  11. 11.
    Aisner, J, Aisner, SC, Ostrow, S, Govindan, S, Mummert, K, Wiernik, P. 1979Meningeal carcinomatosis from small cell carcinoma of the lungConsequence of improved survival. Acta Cytol23292299Google Scholar
  12. 12.
    Aroney, RS, Dalley, DN, Chan, WK, Bell, DR, Levi, JA. 1981Meningeal carcinomatosis in small cell carcinoma of the lungAm J Med712632CrossRefPubMedGoogle Scholar
  13. 13.
    Yap, HY, Yap, BS, Tashima, CK, DiStefano, A, Blumenschein, GR. 1978Meningeal carcinomatosis in breast cancerCancer42283286PubMedGoogle Scholar
  14. 14.
    Jeyapalan, SA, Batchelor, TT. 2000Diagnostic evaluation of neurologic metastasesCancer Invest18381394PubMedGoogle Scholar
  15. 15.
    Rosen, ST, Aisner, J, Makuch, RW, Matthews, MJ, Ihde, DC, Whitacre, M, Glatstein, EJ, Wiernik, PH, Lichter, AS, Bunn, PA,Jr. 1982Carcinomatous leptomeningitis in small cell lung cancer: a clinicopathologic review of the National Cancer Institute experienceMedicine (Baltimore)614553Google Scholar
  16. 16.
    Posner, JB. 1995Leptomeningeal Metastases, in Neurologic Complications of CancerFA DavisPhiladelphia143171Google Scholar
  17. 17.
    Bendell, JC, Domchek, SM, Burstein, HJ, Harris, L, Younger, J, Kuter, I, Bunnell, C, Rue, M, Gelman, R, Winer, E. 2003Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinomaCancer9729722977CrossRefPubMedGoogle Scholar
  18. 18.
    Crivellari, D, Pagani, O, Veronesi, A, Lombardi, D, Nole, F, Thurlimann, B, Hess, D, Borner, M, Bauer, J, Martinelli, G, Graffeo, R, Sessa, C, Goldhirsch, A. 2001High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxelAnn Oncol12353356CrossRefPubMedGoogle Scholar
  19. 19.
    Glass, JP, Melamed, M, Chernik, NL, Posner, JB. 1979Malignant cells in cerebrospinal fluid (CSF): the meaning of a positive CSF cytologyNeurology2913691375PubMedGoogle Scholar
  20. 20.
    Gonzalez-Vitale, JC, Garcia-Bunuel, R. 1976Meningeal carcinomatosisCancer3729062911PubMedGoogle Scholar
  21. 21.
    Kokkoris, CP. 1983Leptomeningeal carcinomatosisHow does cancer reach the pia-arachnoid?. Cancer51154160Google Scholar
  22. 22.
    Bubendorf, L, Schopfer, A, Wagner, U, Sauter, G, Moch, H, Willi, N, Gasser, TC, Mihatsch, MJ. 2000Metastatic patterns of prostate cancer: an autopsy study of 1,589 patientsHum Pathol31578583CrossRefPubMedGoogle Scholar
  23. 23.
    Geldof, AA. 1997Models for cancer skeletal metastasis: a reappraisal of Batson’s plexusAnticancer Res1715351539PubMedGoogle Scholar
  24. 24.
    Boyle, R, Thomas, M, Adams, JH. 1980Diffuse involvement of the leptomeninges by tumour–a clinical and pathological study of 63 casesPostgrad Med J56149158PubMedGoogle Scholar
  25. 25.
    Koch, D. 1996Spinal metastases of cerebral gliomaCase report. Neurosurg Rev19201203Google Scholar
  26. 26.
    Norris, LK, Grossman, SA, Olivi, A. 1997Neoplastic meningitis following surgical resection of isolated cerebellar metastasis: a potentially preventable complicationJ Neurooncol32215223CrossRefPubMedGoogle Scholar
  27. 27.
    Ree, TC, Dippel, DW, Avezaat, CJ, Sillevis Smitt, PA, Vecht, CJ, Bent, MJ. 1999Leptomeningeal metastasis after surgical resection of brain metastasesJ Neurol Neurosurg Psychiatry66225227PubMedGoogle Scholar
  28. 28.
    Hoang-Xuan, K, Napolitano, M, Cornu, P, Delattre, J-Y. 1999Métastases cérébrales et leptoméningées des cancers solidesEncycl Méd Chir (Elsevier, Paris), Neurologie:17225A210Google Scholar
  29. 29.
    Wasserstrom, WR. 1995

    Leptomeningeal metastases

    Wiley, RG. eds. Neurological Complications of Cancer.DekkerNew York4571
    Google Scholar
  30. 30.
    Klein, P, Haley, EC, Wooten, GF, VandenBerg, SR. 1989Focal cerebral infarctions associated with perivascular tumor infiltrates in carcinomatous leptomeningeal metastasesArch Neurol4611491152PubMedGoogle Scholar
  31. 31.
    Madow, L, Alpers, BJ. 1951Encephalitic form of metastatic carcinomaAMA Arch Neurol Psychiatry65161173PubMedGoogle Scholar
  32. 32.
    Hansen, K, Gjerris, F, Sorensen, PS. 1987Absence of hydrocephalus in spite of impaired cerebrospinal fluid absorption and severe intracranial hypertensionActa Neurochir (Wien)869397CrossRefGoogle Scholar
  33. 33.
    Siegal, T, Mildworf, B, Stein, D, Melamed, E. 1985Leptomeningeal metastases: reduction in regional cerebral blood flow and cognitive impairmentAnn Neurol17100102CrossRefPubMedGoogle Scholar
  34. 34.
    Hiesiger, EM, Picco-Del Bo, A, Lipschutz, LE, Basler, GA, Thaler, HT, Posner, JB, Shapiro, WR. 1989Experimental meningeal carcinomatosis selectively depresses local cerebral glucose utilization in rat brainNeurology399095PubMedGoogle Scholar
  35. 35.
    Yap, HY, Tashima, CK, Blumenschein, GR, Eckles, N. 1979Diabetes insipidus and breast cancerArch Intern Med13910091011CrossRefPubMedGoogle Scholar
  36. 36.
    Houck, WA, Olson, KB, Horton, J. 1970Clinical features of tumor metastasis to the pituitaryCancer26656659PubMedGoogle Scholar
  37. 37.
    Marcus, FS, Dandolos, EM, Friedman, MA. 1981Meningeal carcinomatosis in breast cancer presenting as central hypoventilation: a case report with a brief review of the literatureCancer47982984PubMedGoogle Scholar
  38. 38.
    Miller, JW, Klass, DW, Mokri, B, Okazaki, H. 1986Triphasic waves in cerebral carcinomatosisAnother nonmetabolic cause. Arch Neurol4311911193Google Scholar
  39. 39.
    Reuler, JB, Meier, D. 1979Leptomeningeal carcinomatosis with normal CSF featuresArch Intern Med139237238CrossRefPubMedGoogle Scholar
  40. 40.
    Gajjar, A, Fouladi, M, Walter, AW, Thompson, SJ, Reardon, DA, Merchant, TE, Jenkins, JJ, Liu, A, Boyett, JM, Kun, LE, Heideman, RL. 1999Comparison of lumbar and shunt cerebrospinal fluid specimens for cytologic detection of leptomeningeal disease in pediatric patients with brain tumorsJ Clin Oncol1718251828PubMedGoogle Scholar
  41. 41.
    Murray, JJ, Greco, FA, Wolff, SN, Hainsworth, JD. 1983Neoplastic meningitisMarked variations of cerebrospinal fluid composition in the absence of extradural block. Am J Med75289294Google Scholar
  42. 42.
    Klee, GG, Tallman, RD, Goellner, JR, Yanagihara, T. 1986Elevation of carcinoembryonic antigen in cerebrospinal fluid among patients with meningeal carcinomatosisMayo Clin Proc61913PubMedGoogle Scholar
  43. 43.
    Malkin, M, Posner, JB. 1986Perspectives and commentaries: cerebrospinal fluid tumor markers for the diagnosis and management of leptomeningeal metastasesEur J Cancer Clin Oncol22387392CrossRefPubMedGoogle Scholar
  44. 44.
    Cibas, ES, Malkin, MG, Posner, JB, Melamed, MR. 1987Detection of DNA abnormalities by flow cytometry in cells from cerebrospinal fluidAm J Clin Pathol88570577PubMedGoogle Scholar
  45. 45.
    Biesterfeld, S, Bernhard, B, Bamborschke, S, Bocking, A. 1993DNA single cell cytometry in lymphocytic pleocytosis of the cerebrospinal fluidActa Neuropathol (Berl)86428432Google Scholar
  46. 46.
    Dux, R, Kindler-Rohrborn, A, Annas, M, Faustmann, P, Lennartz, K, Zimmermann, CW. 1994A standardized protocol for flow cytometric analysis of cells isolated from cerebrospinal fluidJ Neurol Sci1217478CrossRefPubMedGoogle Scholar
  47. 47.
    Granberg-Ohman, IF, Andersson, BI, Gupta, SK, Lying-Tunell, UM. 1979Chromosome analysis in meningeal carcinomatosisActa Neurol Scand60255259PubMedGoogle Scholar
  48. 48.
    Twinstra A. (2002). Leptomeningeal metastases from solid tumors. EANO V Educational book: 111–115Google Scholar
  49. 49.
    Hoon, DS, Kuo, CT, Wascher, RA, Fournier, P, Wang, HJ, O’Day, SJ. 2001Molecular detection of metastatic melanoma cells in cerebrospinal fluid in melanoma patientsJ Invest Dermatol117375378CrossRefPubMedGoogle Scholar
  50. 50.
    Tosaka, M, Tamura, M, Oriuchi, N, Horikoshi, M, Joshita, T, Sugawara, K, Kobayashi, S, Kohga, H, Yoshida, T, Sasaki, T. 2001Cerebrospinal fluid immunocytochemical analysis and neuroimaging in the diagnosis of primary leptomeningeal melanomaCase report. J Neurosurg94528532Google Scholar
  51. 51.
    Srodon, M, Westra, WH. 2002Immunohistochemical staining for thyroid transcription factor-1: a helpful aid in discerning primary site of tumor origin in patients with brain metastasesHum Pathol33642645CrossRefPubMedGoogle Scholar
  52. 52.
    Schold, SC, Wasserstrom, WR, Fleisher, M, Schwartz, MK, Posner, JB. 1980Cerebrospinal fluid biochemical markers of central nervous system metastasesAnn Neurol8597604CrossRefPubMedGoogle Scholar
  53. 53.
    Fleisher, M, Wasserstrom, WR, Schold, SC, Schwartz, MK, Posner, JB. 1981Lactic dehydrogenase isoenzymes in the cerebrospinal fluid of patients with systemic cancerCancer4726542659PubMedGoogle Scholar
  54. 54.
    Singh, SK, Agris, JM, Leeds, NE, Ginsberg, LE. 2000Intracranial leptomeningeal metastases: comparison of depiction at FLAIR and contrast-enhanced MR imagingRadiology2175053PubMedGoogle Scholar
  55. 55.
    Singh, SK, Leeds, NE, Ginsberg, LE. 2002MR imaging of leptomeningeal metastases: comparison of three sequencesAJNR Am J Neuroradiol23817821PubMedGoogle Scholar
  56. 56.
    Chamberlain, MC, Sandy, AD, Press, GA. 1990Leptomeningeal metastasis: a comparison of gadolinium-enhanced MR and contrast-enhanced CT of the brainNeurology40435438PubMedGoogle Scholar
  57. 57.
    Jaeckle, KA, Krol, G, Posner, JB. 1985Evolution of computed tomographic abnormalities in leptomeningeal metastasesAnn Neurol178589CrossRefPubMedGoogle Scholar
  58. 58.
    Lee, YY, Glass, JP, Geoffray, A, Wallace, S. 1984Cranial computed tomographic abnormalities in leptomeningeal metastasisAJR Am J Roentgenol14310351039PubMedGoogle Scholar
  59. 59.
    Ascherl, GF,Jr., Hilal, SK, Brisman, R. 1981Computed tomography of disseminated meningeal and ependymal malignant neoplasmsNeurology31567574PubMedGoogle Scholar
  60. 60.
    Sze, G, Soletsky, S, Bronen, R, Krol, G. 1989MR imaging of the cranial meninges with emphasis on contrast enhancement and meningeal carcinomatosisAJR Am J Roentgenol15310391049PubMedGoogle Scholar
  61. 61.
    Mason, WP, Yeh, SD, DeAngelis, LM. 1998111Indium-diethylenetriamine pentaacetic acid cerebrospinal fluid flow studies predict distribution of intrathecally administered chemotherapy and outcome in patients with leptomeningeal metastasesNeurology50438444PubMedGoogle Scholar
  62. 62.
    Kim, KS, Ho, SU, Weinberg, PE, Lee, C. 1982Spinal leptomeningeal infiltration by systemic cancer: myelographic featuresAJR Am J Roentgenol139361365PubMedGoogle Scholar
  63. 63.
    Krol, G, Sze, G, Malkin, M, Walker, R. 1988MR of cranial and spinal meningeal carcinomatosis: comparison with CT and myelographyAJR Am J Roentgenol151583588PubMedGoogle Scholar
  64. 64.
    Kramer, ED, Rafto, S, Packer, RJ, Zimmerman, RA. 1991Comparison of myelography with CT follow-up versus gadolinium MRI for subarachnoid metastatic disease in childrenNeurology414650PubMedGoogle Scholar
  65. 65.
    Sze, G, Abramson, A, Krol, G, Liu, D, Amster, J, Zimmerman, RD, Deck, MD. 1988Gadolinium-DTPA in the evaluation of intradural extramedullary spinal diseaseAJR Am J Roentgenol150911921PubMedGoogle Scholar
  66. 66.
    Lim, V, Sobel, DF, Zyroff, J. 1990Spinal cord pial metastases: MR imaging with gadopentetate dimeglumineAJR Am J Roentgenol15510771084PubMedGoogle Scholar
  67. 67.
    Pedersen, AG, Paulson, OB, Gyldensted, C. 1985Metrizamide myelography in patients with small cell carcinoma of the lung suspected of meningeal carcinomatosisJ Neurooncol38589CrossRefPubMedGoogle Scholar
  68. 68.
    Wiener, MD, Boyko, OB, Friedman, HS, Hockenberger, B, Oakes, WJ. 1990False-positive spinal MR findings for subarachnoid spread of primary CNS tumor in postoperative pediatric patientsAJNR Am J Neuroradiol1111001103PubMedGoogle Scholar
  69. 69.
    Rippe, DJ, Boyko, OB, Friedman, HS, Oakes, WJ, Schold, SC,Jr., DeLong, GR, Meisler, WJ. 1990Gd-DTPA-enhanced MR imaging of leptomeningeal spread of primary intracranial CNS tumor in childrenAJNR Am J Neuroradiol11329332PubMedGoogle Scholar
  70. 70.
    Chamberlain, MC. 1995Comparative spine imaging in leptomeningeal metastasesJ Neurooncol23233238CrossRefPubMedGoogle Scholar
  71. 71.
    Yousem, DM, Patrone, PM, Grossman, RI. 1990Leptomeningeal metastases: MR evaluationJ Comput Assist Tomogr14255261PubMedGoogle Scholar
  72. 72.
    Freilich, RJ, Krol, G, DeAngelis, LM. 1995Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasisAnn Neurol385157CrossRefPubMedGoogle Scholar
  73. 73.
    DeAngelis, LM. 1998Current diagnosis and treatment of leptomeningeal metastasisJ Neurooncol38245252CrossRefPubMedGoogle Scholar
  74. 74.
    Chamberlain, MC. 2000Neoplastic meningitis: a guide to diagnosis and treatmentCurr Opin Neurol13641648CrossRefPubMedGoogle Scholar
  75. 75.
    Rodesch, G, Van Bogaert, P, Mavroudakis, N, Parizel, PM, Martin, JJ, Segebarth, C, Van Vyve, M, Baleriaux, D, Hildebrand, J. 1990Neuroradiologic findings in leptomeningeal carcinomatosis: the value interest of gadolinium-enhanced MRINeuroradiology322632CrossRefPubMedGoogle Scholar
  76. 76.
    Gorson, KC, Ropper, AH, Muriello, MA, Blair, R. 1996Prospective evaluation of MRI lumbosacral nerve root enhancement in acute Guillain-Barre syndromeNeurology47813817PubMedGoogle Scholar
  77. 77.
    Joseph, VB, Raghuram, L, Korah, IP, Chacko, AG. 2003MR ventriculography for the study of CSF flowAJNR Am J Neuroradiol24373381PubMedGoogle Scholar
  78. 78.
    Larson, SM, Johnston, GS, Ommaya, AK, Jones, AE, Di Chiro, G. 1973The radionuclide ventriculogramJama224853857CrossRefPubMedGoogle Scholar
  79. 79.
    Di Chiro, G, Hammock, M, Bleyer, A. 1976Spinal descent of cerebrospinal fluid in manNeurology2618PubMedGoogle Scholar
  80. 80.
    Lyons, MK, Meyer, FB. 1990Cerebrospinal fluid physiology and the management of increased intracranial pressureMayo Clin Proc65684707PubMedGoogle Scholar
  81. 81.
    Chamberlain, MC. 1994Pediatric leptomeningeal metastasis: 111In-DTPA cerebrospinal fluid flow studiesJ Child Neurol9150154PubMedGoogle Scholar
  82. 82.
    Chamberlain, MC. 1995Spinal 111Indium-DTPA CSF flow studies in leptomeningeal metastasisJ Neurooncol25135141CrossRefPubMedGoogle Scholar
  83. 83.
    Latchaw, RE, Gabrielsen, TO, Seeger, GF. 1974Cerebral angiography in meningeal sarcomatosis and carcinomatosisNeuroradiology8131139CrossRefGoogle Scholar
  84. 84.
    Cheng, TM, O’Neill, BP, Scheithauer, BW, Piepgras, DG. 1994Chronic meningitis: the role of meningeal or cortical biopsyNeurosurgery34590595discussion 596PubMedGoogle Scholar
  85. 85.
    Pradat PF, Delattre J-Y: Méningites chroniques. Encycl Méd Chir (Elsevier, Paris), Neurologie: 17–160-C-130, 113p, 1995Google Scholar
  86. 86.
    Aichner, F, Schuler, G. 1982Primary leptomeningeal melanomaDiagnosis by ultrastructural cytology of cerebrospinal fluid and cranial computed tomography. Cancer5017511756Google Scholar
  87. 87.
    Savitz, MH, Anderson, PJ. 1974Primary melanoma of the leptomeninges: a reviewMt Sinai J Med41774791PubMedGoogle Scholar
  88. 88.
    Silbert, SW, Smith, KR,Jr., Horenstein, S. 1978Primary leptomeningeal melanoma: an ultrastructural studyCancer41519527PubMedGoogle Scholar
  89. 89.
    Smith, MT, Armbrustmacher, VW, Violett, TW. 1981Diffuse meningeal rhabdomyosarcomaCancer4720812086PubMedGoogle Scholar
  90. 90.
    Machado, M, Salcman, M, Kaplan, RS, Montgomery, E. 1985Expanded role of the cerebrospinal fluid reservoir in neurooncology: indications, causes of revision, and complicationsNeurosurgery17600603PubMedGoogle Scholar
  91. 91.
    Obbens, EA, Leavens, ME, Beal, JW, Lee, YY. 1985Ommaya reservoirs in 387 cancer patients: a 15-year experienceNeurology3512741278PubMedGoogle Scholar
  92. 92.
    Sundaresan, N, Suite, ND. 1989Optimal use of the Ommaya reservoir in clinical oncologyOncology (Huntingt)31522discussion 23Google Scholar
  93. 93.
    Siegal, T. 2003Toxicity of treatment for neoplastic meningitisCurr Oncol Rep54149PubMedGoogle Scholar
  94. 94.
    Chamberlain, M. 1998Leptomeningeal metastases: a review of evaluation and treatmentJ Neurooncol37271284CrossRefPubMedGoogle Scholar
  95. 95.
    Dinndorf, PA, Bleyer, WA. 1987Management of infectious complications of intraventricular reservoirs in cancer patientsq: low incidence and successful treatment without reservoir removalCancer Drug Deliv4105117PubMedGoogle Scholar
  96. 96.
    Siegal, T, Pfeffer, MR, Steiner, I. 1988Antibiotic therapy for infected Ommaya reservoir systemsNeurosurgery2297100PubMedGoogle Scholar
  97. 97.
    Trump, DL, Grossman, SA, Thompson, G, Murray, K. 1982CSF infections complicating the management of neoplastic meningitisClinical features and results of therapy. Arch Intern Med142583586Google Scholar
  98. 98.
    Blasberg, RG, Patlak, C, Fenstermacher, JD. 1975Intrathecal chemotherapy: brain tissue profiles after ventriculocisternal perfusionJ Pharmacol Exp Ther1957383PubMedGoogle Scholar
  99. 99.
    Novak, LJ. 1989Radiotherapy of the central nervous system in acute leukemiaAm J Pediatr Hematol Oncol118792PubMedGoogle Scholar
  100. 100.
    D’Angio, GJ, French, LA, Stadlan, EM, Kieffer, SA. 1968Intrathecal radioisotopes for the treatment of brain tumorsClin Neurosurg15288300PubMedGoogle Scholar
  101. 101.
    Doge, H, Hliscs, R. 1984Intrathecal therapy with 198Au-colloid for meningosis prophylaxisEur J Nucl Med9125128CrossRefPubMedGoogle Scholar
  102. 102.
    Metz, O, Stoll, W, Plenert, W. 1982Meningosis prophylaxis with intrathecal 198Au-colloid and methotrexate in childhood acute lymphocytic leukemiaCancer49224228PubMedGoogle Scholar
  103. 103.
    Benjamin, JC, Moss, T, Moseley, RP, Maxwell, R, Coakham, HB. 1989Cerebral distribution of immunoconjugate after treatment for neoplastic meningitis using an intrathecal radiolabeled monoclonal antibodyNeurosurgery25253258CrossRefPubMedGoogle Scholar
  104. 104.
    Moseley, RP, Davies, AG, Richardson, RB, Zalutsky, M, Carrell, S, Fabre, J, Slack, N, Bullimore, J, Pizer, B, Papanastassiou, V.,  et al. 1990Intrathecal administration of 131I radiolabelled monoclonal antibody as a treatment for neoplastic meningitisBr J Cancer62637642PubMedGoogle Scholar
  105. 105.
    Kramer, K, Cheung, NK, Humm, JL, Dantis, E, Finn, R, Yeh, SJ, Antunes, NL, Dunkel, IJ, Souwedaine, M, Larson, SM. 2000Targeted radioimmunotherapy for leptomeningeal cancer using (131)I-3F8Med Pediatr Oncol35716718CrossRefPubMedGoogle Scholar
  106. 106.
    Bleyer, WA, Poplack, DG, Simon, RM. 1978“Concentration × time” methotrexate via a subcutaneous reservoir: a less toxic regimen for intraventricular chemotherapy of central nervous system neoplasmsBlood51835842PubMedGoogle Scholar
  107. 107.
    Bleyer, WA, Drake, J, Chabner, B. 1973Neurotoxicity and elevated cerebrospinal fluid methotrexate concentration in meningeal leukemiaN Engl J Med289770773PubMedGoogle Scholar
  108. 108.
    Price, R, Jamieson, P. 1975The central nervous system in chidhood leukemiaSub-acute leukoencephalopathy. Cancer35306318Google Scholar
  109. 109.
    Poplack D, Bleyer WA, Horowitz M. Pharmacology of antineoplastic agents in cerebrospinal fluid. 1980Google Scholar
  110. 110.
    Burch, PA, Grossman, SA, Reinhard, CS. 1988Spinal cord penetration of intrathecally administered cytarabine and methotrexate: a quantitative autoradiographic studyJ Natl Cancer Inst8012111216PubMedGoogle Scholar
  111. 111.
    Blaney, S, Poplack, D, Godwin, K, McCully, C, Murphy, RF, Balis, F. 1995The effect of body position on ventricular cerebrospinal fluid methotrexate following intralumbar administrationJ Clin Oncol13177179PubMedGoogle Scholar
  112. 112.
    Shapiro, WR, Young, DF, Mehta, BM. 1975Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injectionsN Engl J Med293161166PubMedGoogle Scholar
  113. 113.
    Chamberlain, MC, Khatibi, S, Kim, JC, Howell, SB, Chatelut, E, Kim, S. 1993Treatment of leptomeningeal metastasis with intraventricular administration of depot cytarabine (DTC 101)A phase I study. Arch Neurol50261264Google Scholar
  114. 114.
    Kim, S, Chatelut, E, Kim, JC, Howell, SB, Cates, C, Kormanik, PA, Chamberlain, MC. 1993Extended CSF cytarabine exposure following intrathecal administration of DTC 101J Clin Oncol1121862193PubMedGoogle Scholar
  115. 115.
    Ettinger, L, Chervinsky, D, Freeman, A, Creaven, PJ. 1982Pharmacokinetics of methotrexate following intravenous and intraventricular administration in acute lymphocitic leukemia and non-Hodgkin’s lymphomaCancer5016761682PubMedGoogle Scholar
  116. 116.
    Trump, DL, Grossman, SA, Thompson, G, Murray, K, Wharam, M. 1982Treatment of neoplastic meningitis with intraventricular thiotepa and methotrexateCancer Treat Rep6615491551PubMedGoogle Scholar
  117. 117.
    Strother, DR, Glynn-Barnhart, A, Kovnar, E, Gregory, RE, Murphy, SB. 1989Variability in the disposition of intraventricular methotrexate: a proposal for rational dosingJ Clin Oncol717411747PubMedGoogle Scholar
  118. 118.
    Moser, AM, Adamson, PC, Gillespie, AJ, Poplack, DGB, Balis, FM. 1999Intraventricular Concentration times time (CxT) methotrexate and cytarabine for patients with recurrent meningeal leukemia and lymphomaCancer85511556CrossRefPubMedGoogle Scholar
  119. 119.
    Petit, T, Dufour, P, Korganov, AS, Maloisel, F, Oberling, F. 1997Continuous intrathecal perfusion of methotrexate for carcinomatous meningitis with pharmacokinetic studies: two case studiesClin Oncol9189190CrossRefGoogle Scholar
  120. 120.
    Adamson, PC, Balis, FM, Arndt, CA, Holcenberg, JS, Narang, PK, Murphy, RF, Gillespie, AJ, Poplack, DG. 1991Intrathecal 6-mercaptopurine: preclinical pharmacology, phase I/II trial, and pharmacokinetic studyCancer Res5160796083PubMedGoogle Scholar
  121. 121.
    Zimm, S, Collins, JM, Miser, J, Chatterji, D, Poplack, D. 1984Cytosine arabinoside cerebrospinal fluid kineticsClin Pharmacol Therap35826830Google Scholar
  122. 122.
    Glantz, MJ, Jaeckle, KA, Chamberlain, MC, Phuphanich, S, Recht, L, Swinnen, LJ, Maria, B, LaFollette, S, Schumann, GB, Cole, BF, Howell, SB. 1999A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumorsClin Cancer Research533943402Google Scholar
  123. 123.
    Grossman, SA, Finkelstein, DM, Ruckdeschel, JC, Trump, DL, Moynihan, T, Ettinger, DS. 1993Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitisEastern Cooperative Oncology Group. J Clin Oncol11561569Google Scholar
  124. 124.
    Mellett, LB. 1977Physicochemical considerations and pharmacokinetic behavior in delivery of drugs to the central nervous systemCancer Treat Rep61527531PubMedGoogle Scholar
  125. 125.
    Siegal, T, Lossos, A, Pfeffer, MR. 1994Leptomeningeal metastases: analysis of 31 patients with sustained off-therapy response following combined-modality therapyNeurology4414631469PubMedGoogle Scholar
  126. 126.
    Boogerd, W, Hart, AA, Sande, JJ, Engelsman, E. 1991Meningeal carcinomatosis in breast cancerPrognostic factors and influence of treatment. Cancer6716851695Google Scholar
  127. 127.
    Grant, R, Naylor, B, Greenberg, HS, Junck, L. 1994Clinical outcome in aggressively treated meningeal carcinomatosisArch Neurol51457461PubMedGoogle Scholar
  128. 128.
    Fizazi, K, Asselain, B, Vincent-Salomon, A, Jouve, M, Dieras, V, Palangie, T, Beuzeboc, P, Dorval, T, Pouillart, P. 1996Meningeal carcinomatosis in patients with breast carcinomaClinical features, prognostic factors, and results of a high-dose intrathecal methotrexate regimen. Cancer7713151323Google Scholar
  129. 129.
    Bokstein, F, Lossos, A, Siegal, T. 1998Leptomeningeal metastases from solid tumors: a comparison of two prospective series treated with and without intra-cerebrospinal fluid chemotherapyCancer8217561763CrossRefPubMedGoogle Scholar
  130. 130.
    Bokstein, F, Lossos, A, Siegal, T. 1997Leptomeningeal metastases in solid tumors: exclusion of intra-CSF chemotherapy does not affect treatment outcomeComparison of two prospective series. Neurology48A35Google Scholar
  131. 131.
    Siegal, T. 1998Leptomeningeal metastases: rationale for systemic chemotherapy or what is the role of intra-CSF-chemotherapy?J Neurooncol38151157CrossRefPubMedGoogle Scholar
  132. 132.
    Chamberlain, MC, Kormanik, P. 1998Carcinoma meningitis secondary to non-small cell lung cancer: combined modality therapyArch Neurol55506512CrossRefPubMedGoogle Scholar
  133. 133.
    Donehower, R, Karp, J, Burke, P. 1986Pharmacology and toxicity of high-dose cytarabine by 72-hour continuous infusionCancer Treat Rep7010591065PubMedGoogle Scholar
  134. 134.
    Morra, E, Lazzarino, M, Brusamolino, E, Pagnucco, G, Castagnola, C, Bernasconi, P, Orlandi, E, Corso, A, Santagostino, A, Bernasconi, C. 1993The role of systemic high-dose cytarabine in the treatment of central nervous system leukemia Clinical results in 46 patients.Cancer72439445PubMedGoogle Scholar
  135. 135.
    Slevin, ML, Piall, EM, Aherne, GW, Harvey, VJ, Johnston, A, Lister, TA. 1983Effect of dose and schedule on pharmacokinetics of high-dose cytosine arabinoside in plasma and cerebrospinal fluidJ Clin Oncol1546551PubMedGoogle Scholar
  136. 136.
    Ozdogan, M, Samur, M, Bozcuk, HS, Sagtas, E, Yildiz, M, Artac, M, Savas, B. 2003Durable remission of leptomeningeal metastasis of breast cancer with letrozole: a case report and implications of biomarkers on treatment selectionJpn J Clin Oncol33229231CrossRefPubMedGoogle Scholar
  137. 137.
    Boogerd, W, Dorresteijn, LD, Sande, JJ, Gast, GC, Bruning, PF. 2000Response of leptomeningeal metastases from breast cancer to hormonal therapyNeurology55117119PubMedGoogle Scholar
  138. 138.
    Zovickian, J, Youle, RJ. 1988Efficacy of intrathecal immunotoxin therapy in an animal model of leptomeningeal neoplasiaJ Neurosurg68767774PubMedGoogle Scholar
  139. 139.
    Friedman, HS. 2000Temozolomide in early stages of newly diagnosed malignant glioma and neoplastic meningitisSemin Oncol273540PubMedGoogle Scholar
  140. 140.
    Berg, SL, Balis, FM, Zimm, S, Murphy, RF, Holcenberg, J, Sato, J, Reaman, G, Steinherz, P, Gillespie, A, Doherty, K.,  et al. 1992Phase I/II trial and pharmacokinetics of intrathecal diaziquone in refractory meningeal malignanciesJ Clin Oncol10143148PubMedGoogle Scholar
  141. 141.
    Blaney, S, Balis, F, Murphy, RF, Arndt, CA, Gillepsie, A, Poplack, DG. 1992A phase I study of intrathecal mafosfamide (MF) in patients with refractory meningeal malignancies. (Abstract 274)Proc Am Soc Clin Oncol11113Google Scholar
  142. 142.
    Levin, VA, Chamberlain, M, Silver, P, Rodriguez, L, Prados, M. 1989Phase I/II study of intraventricular and intrathecal ACNU for leptomeningeal neoplasiaCancer Chemother Pharmacol23301307CrossRefPubMedGoogle Scholar
  143. 143.
    List, J, Moser, RP, Steuer, M, Loudon, WG, Blacklock, JB, Grimm, EA. 1992Cytokine responses to intraventricular injection of interleukin 2 into patients with leptomeningeal carcinomatosis: rapid induction of tumor necrosis factor alpha, interleukin 1 beta, interleukin 6, gamma-interferon, and soluble interleukin 2 receptor (Mr 55,000 protein)Cancer Res5211231128PubMedGoogle Scholar
  144. 144.
    Balis, FM, Poplack, DG. 1989Central nervous system pharmacology of antileukemic drugsAm J Pediatr Hematol Oncol117486PubMedGoogle Scholar
  145. 145.
    Strong, JM, Collins, JM, Lester, C, Poplack, DG. 1986Pharmacokinetics of intraventricular and intravenous N,N’,N”-triethylenethiophosphoramide (thiotepa) in rhesus monkeys and humansCancer Res4661016104PubMedGoogle Scholar
  146. 146.
    Witham, TF, Fukui, MB, Meltzer, CC, Burns, R, Kondziolka, D, Bozik, ME. 1999Survival of patients with high grade glioma treated with intrathecal thiotriethylenephosphoramide for ependymal or leptomeningeal gliomatosisCancer8613471353CrossRefPubMedGoogle Scholar
  147. 147.
    Chen, YM, Chen, MC, Tsai, CM, Perng, RP. 2003Intrathecal gemcitabine chemotherapy for non-small cell lung cancer patients with meningeal carcinomatosis–a case reportLung Cancer4099101CrossRefPubMedGoogle Scholar
  148. 148.
    Cokgor, I, Friedman, AH, Friedman, HS. 2002Current options for the treatment of neoplastic meningitisJ Neurooncol607988CrossRefPubMedGoogle Scholar
  149. 149.
    Blaney, SM, Heideman, R, Berg, S, Adamson, P, Gillespie, A, Geyer, JR, Packer, R, Matthay, K, Jaeckle, K, Cole, D, Kuttesch, N, Poplack, DG, Balis, FM. 2003Phase I clinical trial of intrathecal topotecan in patients with neoplastic meningitisJ Clin Oncol21143147CrossRefPubMedGoogle Scholar
  150. 150.
    Oldfield, EH, Ram, Z, Chiang, Y, Blaese, RM. 1995Intrathecal gene therapy for the treatment of leptomeningeal carcinomatosis. GTI 0108A phase I/II study. Hum Gene Ther65585Google Scholar
  151. 151.
    Rosenfeld, MR, Bergman, I, Schramm, L, Griffin, JA, Kaplitt, MG, Meneses, PI. 1997Adeno-associated viral vector gene transfer into leptomeningeal xenograftsJ Neurooncol34139144CrossRefPubMedGoogle Scholar
  152. 152.
    Viola, JJ, Ram, Z, Walbridge, S, Oshiro, EM, Trapnell, B, Tao-Cheng, JH, Oldfield, EH. 1995Adenovirally mediated gene transfer into experimental solid brain tumors and leptomeningeal cancer cellsJ Neurosurg827076PubMedGoogle Scholar
  153. 153.
    Brown, MT, Coleman, RE, Friedman, AH, Friedman, HS, McLendon, RE, Reiman, R, Felsberg, CJ, Tien, RD, Bigner, SH, Zalutsky, MR, Zhao, XG, Wikstrand, CJ, Pegram, CN, Herndon, JEn, Vick, NA, Paleologos, N, Frederiks, RK, Schold, SCJ, Bigner, DD. 1996Intrathecal 131 I-labeled antitenascin monoclonal antibody 81C6 treatment of patients with leptomeningeal neoplasms or primary brain tumor resection cavities with subarachnoid communication: phase I trial resultsClin Cancer Res2963972PubMedGoogle Scholar
  154. 154.
    Cokgor, I, Akabani, G, Friedman, HS, Friedman, AH, Zatusky, MR, Zehngebot, LM, Provenzale, JM, Guy, CD, Wikstrand, CJ. 2001Long term response in a patient with neoplastic meningitis secondary to melnoma treated with (131) I-radiolabeled anti-chondroitin proteoglycan sulfate Mel-14 F(ab’) (2): a case studyCancer9118091813CrossRefPubMedGoogle Scholar
  155. 155.
    Archer, GE, Sampson, JH, Lorimer, IA, McLendon, RE, Kuan, CT, Friedman, AH, Friedman, HS, Pastan, IH, Bigner, DD. 1999Regional treatment of epidermal growth factor receptor vIII-expressing neoplastic meningitis with a single-chain immunotoxin, MR-IClin Cancer Research526462652Google Scholar
  156. 156.
    Bigner, DD, Archer, GE, McLendon, RE, Friedman, HS, Fuchs, HE, Pai, LH, Herndon, JEn, Pastan, IH. 1995Efficacy of compartmental administration of immunotoxin LMB-1 (B3-LysPE38) in a rat model of carcinomatous meningitisClin Cancer Res115451555PubMedGoogle Scholar
  157. 157.
    Reijneveld, JC, Taphoorn, MJ, Kerckhaert, OA, Drixler, TA, Boogerd, W, Voest, EE. 2003Angiostatin prolongs the survival of mice with leptomeningeal metastasesEur J Clin Invest337681CrossRefPubMedGoogle Scholar
  158. 158.
    Brandsma, D, Reijneveld, JC, Taphoorn, MJ, Boer, HC, Gebbink, MF, Ulfman, LH, Zwaginga, JJ, Voest, EE. 2002Vascular cell adhesion molecule-1 is a key adhesion molecule in melanoma cell adhesion to the leptomeningesLab Invest8214931502PubMedGoogle Scholar
  159. 159.
    Laufman, LR, Forsthoefel, KF. 2001Use of intrathecal trastuzumab in a patient with carcinomatous meningitisClin Breast Cancer2235PubMedGoogle Scholar
  160. 160.
    Robins, HI, Liu, G, Hayes, L, Mehta, M. 2002Trastuzumab for breast cancer-related carcinomatous meningitisClin Breast Cancer2316PubMedGoogle Scholar
  161. 161.
    Renbarger, J, Aleksic, A, McGuffey, L, Dauser, R, Berg, S, Blaney, S. 2004Plasma and cerebrospinal fluid pharmacokinetics of SU5416 after intravenous administration in nonhuman primatesCancer Chemother Pharmacol533942CrossRefPubMedGoogle Scholar
  162. 162.
    Lashfford, LS, Davies, AG, Richardson, RB, Bourne, SP, Bullimore, JA, Eckert, H, Kemshead, JT, Coakham, HB. 1988A pilot study of 131I monoclonal antibodies in the therapy of leptomeningeal tumorsCancer61857868PubMedGoogle Scholar
  163. 163.
    Moseley, RP, Benjamin, JC, Ashpole, RD, Sulli #132;van, NM, Bullimore, JA, Coakham, HB, Kemshead, JT. 1991Carcinomatous meningitis: antibody-guided therapy with I-131 HMFG1J Neurol Neurosurg Psychiatry54260265PubMedGoogle Scholar
  164. 164.
    Hisanaga, M, Kawai, S, Maekawa, M, Hattori, Y, Kotoh, K. 1988[Neoplastic aneurysms due to cerebral metastasis of choriocarcinomaReport of two cases]. Neurol Med Chir (Tokyo)28398403Google Scholar
  165. 165.
    Kemshead, JT, Papanastassiou, V, Coakham, HB, Pizer, BL. 1992Monoclonal antibodies in the treatment of central nervous system malignanciesEur J Cancer28511513PubMedGoogle Scholar
  166. 166.
    Myklebust, AT, Godal, A, Fodstad, O. 1994Targeted therapy with immunotoxins in a nude rat model for leptomeningeal growth of human small cell lung cancerCancer Res5421462150PubMedGoogle Scholar
  167. 167.
    Johnson, VG, Wrobel, C, Wilson, D, Zovickian, J, Greenfield, L, Oldfield, EH, Youle, R. 1989Improved tumor-specific immunotoxins in the treatment of CNS and leptomeningeal neoplasiaJ Neurosurg70240248PubMedGoogle Scholar
  168. 168.
    Hall, WA, Fodstad, O. 1992Immunotoxins and central nervous system neoplasiaJ Neurosurg76112PubMedGoogle Scholar
  169. 169.
    Youle, RJ. 1996Immunotoxins for central nervous system malignancySemin Cancer Biol76570CrossRefPubMedGoogle Scholar
  170. 170.
    Laske, DW, Muraszko, KM, Oldfield, EH, Vroom, HL, Sung, C, Dedrick, RL, Simon, TR, Colandrea, J, Copeland, C, Katz, D, Greenfield, L, Groves, ES, Houston, LL, Youle, RJ. 1997Intraventricular immunotoxin therapy for leptomeningeal neoplasiaNeurosurgery4110391049discussion 1049–1051CrossRefPubMedGoogle Scholar
  171. 171.
    Glantz, MJ, LaFollette, S, Jaeckle, K. 1999Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitisJ Clin Oncol1731103116PubMedGoogle Scholar
  172. 172.
    Liaw, CC, Ng, KT, Huang, JS, Wang, CH, Kiu, MC, Lai, GM. 1992Meningeal carcinomatosis from solid tumors: clinical analysis of 42 casesJ Formos Med Assoc91299303PubMedGoogle Scholar
  173. 173.
    Ongerboer de Visser, BW, Somers, R, Nooyen, WH, Heerde, P, Hart, AA, McVie, JG. 1983Intraventricular methotrexate therapy of leptomeningeal metastasis from breast carcinomaNeurology3315651572PubMedGoogle Scholar
  174. 174.
    Yap, HY, Yap, BS, Rasmussen, S, Levens, ME, Hortobagyi, GN, Blumenschein, GR. 1982Treatment for meningeal carcinomatosis in breast cancerCancer50219222PubMedGoogle Scholar
  175. 175.
    Sause, WT, Crowley, J, Eyre, HJ, Rivkin, SE, Pugh, RP, Quagliana, JM, Taylor, SA, Molnar, B. 1988Whole brain irradiation and intrathecal methotrexate in the treatment of solid tumor leptomeningeal metastases–a Southwest Oncology Group studyJ Neurooncol6107112PubMedGoogle Scholar
  176. 176.
    Schabet, M, Kloeter, I, Adam, T, Heidemann, E, Wietholter, H. 1986Diagnosis and treatment of meningeal carcinomatosis in ten patients with breast cancerEur Neurol25403411PubMedGoogle Scholar
  177. 177.
    Pfeffer, MR, Wygoda, M, Siegal, T. 1988Leptomeningeal metastases–treatment results in 98 consecutive patientsIsr J Med Sci24611618PubMedGoogle Scholar
  178. 178.
    Nakagawa, H, Murasawa, A, Kubo, S, Nakajima, S, Nakajima, Y, Izumoto, S, Hayakawa, T. 1992Diagnosis and treatment of patients with meningeal carcinomatosisJ Neurooncol138189CrossRefPubMedGoogle Scholar
  179. 179.
    Chamberlain, MC, Kormanik, PA. 1996Prognostic significance of 111indium-DTPA CSF flow studies in leptomeningeal metastasesNeurology4616741677PubMedGoogle Scholar
  180. 180.
    Chamberlain, MC, Kormanik, PA. 1997Prognostic significance of coexistent bulky metastatic central nervous system disease in patients with leptomeningeal metastasesArch Neurol5413641368PubMedGoogle Scholar
  181. 181.
    Grossman, SA, Trump, DL, Chen, DC, Thompson, G, Camargo, EE. 1982Cerebrospinal fluid flow abnormalities in patients with neoplastic meningitisAn evaluation using 111 indium-DTPA ventriculography. Am J Med73641647Google Scholar
  182. 182.
    Grant, R, Naylor, B, Junck, L, Greenberg, HS. 1992Clinical outcome in aggressively treated meningeal gliomatosisNeurology42252254PubMedGoogle Scholar

Copyright information

© Springer 2005

Authors and Affiliations

  • Sophie Taillibert
    • 1
  • Florence Laigle-Donadey
    • 1
  • Catherine Chodkiewicz
    • 2
  • Marc Sanson
    • 1
  • Khê Hoang-Xuan
    • 1
  • Jean-Yves Delattre
    • 1
  1. 1.Fédération de NeurologieBatîment Mazarin, Groupe hospitalier Pitié-SalpétrièreParisFrance
  2. 2.Department of Interdisciplinary OncologyH. Lee Moffitt Cancer Center & Research InstituteTampaUSA

Personalised recommendations